Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2015-10-14 Tx date 2015-10-07 |
$AMF
ProMIS Neurosciences Inc. |
Kirwin, Patrick D.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$20,000
+250,000 vol $0.08 each |
250,000 | |
Filed 2015-10-14 Tx date 2015-06-29 |
$AMF
ProMIS Neurosciences Inc. |
Kirwin, Patrick D.
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2015-10-13 Tx date 2015-10-07 |
$AMF
ProMIS Neurosciences Inc. |
Wyman, William Williams
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$16,000
+200,000 vol $0.08 each |
200,000 | |
Filed 2015-10-13 Tx date 2015-10-07 |
$AMF
ProMIS Neurosciences Inc. |
Wyman, William Williams
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-380,000
-1,000,000 vol $0.38 each |
0 | |
Filed 2015-10-13 Tx date 2015-10-07 |
$AMF
ProMIS Neurosciences Inc. |
Roth, Johannes Minho
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$20,000
+250,000 vol $0.08 each |
462,000 | |
Filed 2015-10-13 Tx date 2015-10-07 |
$AMF
ProMIS Neurosciences Inc. |
Roth, Johannes Minho
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$16,000
+200,000 vol $0.08 each |
212,000 | |
Filed 2015-10-13 Tx date 2015-10-07 |
$AMF
ProMIS Neurosciences Inc. |
Roth, Johannes Minho
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$960.00
+12,000 vol $0.08 each |
12,000 | |
Filed 2015-10-13 Tx date 2015-10-07 |
$AMF
ProMIS Neurosciences Inc. |
Roth, Johannes Minho
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-380,000
-1,000,000 vol $0.38 each |
0 | |
Filed 2015-10-13 Tx date 2015-10-07 |
$AMF
ProMIS Neurosciences Inc. |
Roth, Johannes Minho
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-22,800
-60,000 vol $0.38 each |
1,000,000 | |
Filed 2015-10-13 Tx date 2015-10-07 |
$AMF
ProMIS Neurosciences Inc. |
Clennett, Janet Barbara
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$800.00
+10,000 vol $0.08 each |
37,367 | |
Filed 2015-10-13 Tx date 2015-10-07 |
$AMF
ProMIS Neurosciences Inc. |
Clennett, Janet Barbara
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$933.36
+11,667 vol $0.08 each |
27,367 | |
Filed 2015-10-13 Tx date 2015-10-07 |
$AMF
ProMIS Neurosciences Inc. |
Clennett, Janet Barbara
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$640.00
+8,000 vol $0.08 each |
15,700 | |
Filed 2015-10-13 Tx date 2015-10-07 |
$AMF
ProMIS Neurosciences Inc. |
Clennett, Janet Barbara
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$320.00
+4,000 vol $0.08 each |
7,700 | |
Filed 2015-10-13 Tx date 2015-10-07 |
$AMF
ProMIS Neurosciences Inc. |
Clennett, Janet Barbara
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$144.00
+1,800 vol $0.08 each |
3,700 | |
Filed 2015-10-13 Tx date 2015-10-07 |
$AMF
ProMIS Neurosciences Inc. |
Clennett, Janet Barbara
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$80.00
+1,000 vol $0.08 each |
1,900 | |
Filed 2015-10-13 Tx date 2015-10-07 |
$AMF
ProMIS Neurosciences Inc. |
Clennett, Janet Barbara
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$72.00
+900 vol $0.08 each |
900 | |
Filed 2015-10-13 Tx date 2015-10-07 |
$AMF
ProMIS Neurosciences Inc. |
Clennett, Janet Barbara
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-19,000
-50,000 vol $0.38 each |
0 | |
Filed 2015-10-13 Tx date 2015-10-07 |
$AMF
ProMIS Neurosciences Inc. |
Clennett, Janet Barbara
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-20,999.88
-58,333 vol $0.36 each |
50,000 | |
Filed 2015-10-13 Tx date 2015-10-07 |
$AMF
ProMIS Neurosciences Inc. |
Clennett, Janet Barbara
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-2,300
-10,000 vol $0.23 each |
108,333 | |
Filed 2015-10-13 Tx date 2015-10-07 |
$AMF
ProMIS Neurosciences Inc. |
Clennett, Janet Barbara
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-6,900
-30,000 vol $0.23 each |
118,333 | |
Filed 2015-10-13 Tx date 2015-10-07 |
$AMF
ProMIS Neurosciences Inc. |
Clennett, Janet Barbara
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-8,600
-20,000 vol $0.43 each |
148,333 | |
Filed 2015-10-13 Tx date 2015-10-07 |
$AMF
ProMIS Neurosciences Inc. |
Clennett, Janet Barbara
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-9,000
-9,000 vol $1.00 each |
168,333 | |
Filed 2015-10-13 Tx date 2015-10-07 |
$AMF
ProMIS Neurosciences Inc. |
Clennett, Janet Barbara
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-2,925
-4,500 vol $0.65 each |
182,333 | |
Filed 2015-10-13 Tx date 2015-10-07 |
$AMF
ProMIS Neurosciences Inc. |
Clennett, Janet Barbara
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-4,650
-5,000 vol $0.93 each |
177,333 | |
Filed 2015-10-13 Tx date 2015-10-07 |
$AMF
ProMIS Neurosciences Inc. |
Wyman, William Williams
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$20,000
+250,000 vol $0.08 each |
450,000 | |
Filed 2015-09-21 Tx date 2015-09-17 |
$AMF
ProMIS Neurosciences Inc. |
Cashman, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-7,800
-12,000 vol $0.65 each |
7,575,583 | |
Filed 2015-09-21 Tx date 2015-09-17 |
$AMF
ProMIS Neurosciences Inc. |
Cashman, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-12,000
-12,000 vol $1.00 each |
7,563,583 | |
Filed 2015-09-21 Tx date 2015-09-17 |
$AMF
ProMIS Neurosciences Inc. |
Cashman, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-11,160
-12,000 vol $0.93 each |
7,587,583 | |
Filed 2015-09-21 Tx date 2015-09-17 |
$AMF
ProMIS Neurosciences Inc. |
Cashman, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-19,800
-60,000 vol $0.33 each |
7,503,583 | |
Filed 2015-09-21 Tx date 2015-09-17 |
$AMF
ProMIS Neurosciences Inc. |
Cashman, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-10,750
-25,000 vol $0.43 each |
7,478,583 | |
Filed 2015-09-21 Tx date 2015-09-17 |
$AMF
ProMIS Neurosciences Inc. |
Cashman, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-24,750
-110,000 vol $0.225 each |
7,368,583 | |
Filed 2015-09-21 Tx date 2015-09-17 |
$AMF
ProMIS Neurosciences Inc. |
Cashman, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-57,600
-160,000 vol $0.36 each |
7,208,583 | |
Filed 2015-09-21 Tx date 2015-09-17 |
$AMF
ProMIS Neurosciences Inc. |
Cashman, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-98,800
-260,000 vol $0.38 each |
6,948,583 | |
Filed 2015-09-21 Tx date 2015-09-16 |
$AMF
ProMIS Neurosciences Inc. |
Roth, Johannes Minho
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-360,000
-1,000,000 vol $0.36 each |
1,060,000 | |
Filed 2015-08-24 Tx date 2015-08-15 |
$AMF
ProMIS Neurosciences Inc. |
Clennett, Janet Barbara
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
186,833 | ||
Filed 2015-08-04 Tx date 2015-07-31 |
$AMF
ProMIS Neurosciences Inc. |
Williams, Eugene Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$30,000
+1,000,000 vol $0.03 each |
3,000,000 | |
Filed 2015-08-04 Tx date 2015-07-31 |
$AMF
ProMIS Neurosciences Inc. |
Williams, Eugene Warren
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$144,253
+2,219,283 vol $0.065 each |
6,948,583 | |
Filed 2015-08-04 Tx date 2015-07-31 |
$AMF
ProMIS Neurosciences Inc. |
Goldstein, Elliot Paul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$144,253
+2,219,283 vol $0.065 each |
6,948,583 | |
Filed 2015-08-04 Tx date 2015-07-31 |
$AMF
ProMIS Neurosciences Inc. |
Goldstein, Elliot Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$12,000
+400,000 vol $0.03 each |
2,400,000 | |
Filed 2015-08-04 Tx date 2015-07-31 |
$AMF
ProMIS Neurosciences Inc. |
Cashman, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$144,253
+2,219,283 vol $0.065 each |
7,599,583 | |
Filed 2015-07-31 Tx date 2015-07-31 |
$AMF
ProMIS Neurosciences Inc. |
Bigger, Michael
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$60,000
+2,000,000 vol $0.03 each |
8,136,250 | |
Filed 2015-07-13 Tx date 2015-07-06 |
$AMF
Amorfix Life Sciences Ltd. |
Goldstein, Elliot Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$60,000
+2,000,000 vol $0.03 each |
2,000,000 | |
Filed 2015-07-13 Tx date 2015-07-06 |
$AMF
Amorfix Life Sciences Ltd. |
Goldstein, Elliot Paul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$191,536
+4,729,300 vol $0.0405 each |
4,729,300 | |
Filed 2015-07-13 Tx date 2014-09-04 |
$AMF
Amorfix Life Sciences Ltd. |
Goldstein, Elliot Paul
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2015-07-13 Tx date 2014-09-04 |
$AMF
Amorfix Life Sciences Ltd. |
Goldstein, Elliot Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2015-07-11 Tx date 2015-07-06 |
$AMF
Amorfix Life Sciences Ltd. |
Cashman, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$191,536
+4,729,300 vol $0.0405 each |
5,380,300 | |
Filed 2015-07-11 Tx date 2015-07-06 |
$AMF
Amorfix Life Sciences Ltd. |
Williams, Eugene Warren
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$191,536
+4,729,300 vol $0.0405 each |
4,729,300 | |
Filed 2015-07-11 Tx date 2015-06-30 |
$AMF
Amorfix Life Sciences Ltd. |
Williams, Eugene Warren
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2015-07-11 Tx date 2015-07-06 |
$AMF
Amorfix Life Sciences Ltd. |
Williams, Eugene Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$60,000
+2,000,000 vol $0.03 each |
2,000,000 | |
Filed 2015-07-11 Tx date 2015-06-30 |
$AMF
Amorfix Life Sciences Ltd. |
Williams, Eugene Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2015-07-11 Tx date 2015-07-06 |
$AMF
Amorfix Life Sciences Ltd. |
Wyman, William Williams
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$60,000
+2,000,000 vol $0.03 each |
3,170,000 | |
Filed 2015-07-11 Tx date 2015-07-06 |
$AMF
Amorfix Life Sciences Ltd. |
Cashman, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$9,000
+300,000 vol $0.03 each |
5,155,644 | |
Filed 2015-07-10 Tx date 2015-07-06 |
$AMF
Amorfix Life Sciences Ltd. |
Kirwin, Patrick D.
4 - Director of Issuer
Holder: Jeananne Kirwin (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$15,000
+500,000 vol $0.03 each |
||
Filed 2015-07-10 Tx date 2015-07-06 |
$AMF
Amorfix Life Sciences Ltd. |
Kirwin, Patrick D.
4 - Director of Issuer
Holder: Jeananne Kirwin (Control or Direction)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$15,000
+500,000 vol $0.03 each |
593,900 | |
Filed 2015-07-09 Tx date 2015-07-06 |
$AMF
Amorfix Life Sciences Ltd. |
Kirwin, Patrick D.
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$15,000
+500,000 vol $0.03 each |
1,002,200 | |
Filed 2015-07-09 Tx date 2015-07-06 |
$AMF
Amorfix Life Sciences Ltd. |
Bigger, Michael
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
6,136,250 | ||
Filed 2015-07-09 Tx date 2015-07-06 |
$AMF
Amorfix Life Sciences Ltd. |
Kirwin, Patrick D.
4 - Director of Issuer
Holder: Jeananne Kirwin (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$15,000
+500,000 vol $0.03 each |
593,900 | |
Filed 2015-07-09 Tx date 2015-07-06 |
$AMF
Amorfix Life Sciences Ltd. |
Bigger, Michael
3 - 10% Security Holder of Issuer
Holder: Mathias Bigger (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
3,068,125 | ||
Filed 2015-07-09 Tx date 2015-07-06 |
$AMF
Amorfix Life Sciences Ltd. |
Kirwin, Patrick D.
4 - Director of Issuer
Holder: Patrick D Kirwin Professional Corporation (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$15,000
+500,000 vol $0.03 each |
639,900 | |
Filed 2015-07-09 Tx date 2015-06-29 |
$AMF
Amorfix Life Sciences Ltd. |
Kirwin, Patrick D.
4 - Director of Issuer
Holder: Patrick D Kirwin Professional Corporation (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
139,900 | ||
Filed 2015-07-09 Tx date 2015-07-06 |
$AMF
Amorfix Life Sciences Ltd. |
Bigger, Michael
3 - 10% Security Holder of Issuer
Holder: Andreas Bigger (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
3,068,125 | ||
Filed 2015-07-09 Tx date 2015-06-29 |
$AMF
Amorfix Life Sciences Ltd. |
Kirwin, Patrick D.
4 - Director of Issuer
Holder: Jeananne Kirwin (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
93,900 | ||
Filed 2015-07-09 Tx date 2015-06-29 |
$AMF
Amorfix Life Sciences Ltd. |
Kirwin, Patrick D.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
502,200 |